PL3630806T3 - Analogi peptydów gip o długotrwałym działaniu - Google Patents
Analogi peptydów gip o długotrwałym działaniuInfo
- Publication number
- PL3630806T3 PL3630806T3 PL18728872.5T PL18728872T PL3630806T3 PL 3630806 T3 PL3630806 T3 PL 3630806T3 PL 18728872 T PL18728872 T PL 18728872T PL 3630806 T3 PL3630806 T3 PL 3630806T3
- Authority
- PL
- Poland
- Prior art keywords
- long
- peptide analogues
- gip peptide
- acting
- acting gip
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17173628 | 2017-05-31 | ||
| PCT/EP2018/064355 WO2018220123A1 (en) | 2017-05-31 | 2018-05-31 | Long-acting gip peptide analogues |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3630806T3 true PL3630806T3 (pl) | 2024-05-13 |
Family
ID=59021262
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18728872.5T PL3630806T3 (pl) | 2017-05-31 | 2018-05-31 | Analogi peptydów gip o długotrwałym działaniu |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11572399B2 (enExample) |
| EP (2) | EP4361173A3 (enExample) |
| JP (1) | JP2020521784A (enExample) |
| KR (1) | KR102743887B1 (enExample) |
| CN (1) | CN110691788B (enExample) |
| AU (1) | AU2018276434B2 (enExample) |
| BR (1) | BR112019025195A8 (enExample) |
| ES (1) | ES2972848T3 (enExample) |
| PL (1) | PL3630806T3 (enExample) |
| WO (1) | WO2018220123A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016034186A1 (en) | 2014-09-05 | 2016-03-10 | University Of Copenhagen | Gip peptide analogues |
| KR102743887B1 (ko) | 2017-05-31 | 2024-12-19 | 유니버시티 오브 코펜하겐 | 장기-작용성 gip 펩타이드 유사체 |
| MX2020011427A (es) | 2018-05-04 | 2020-12-07 | Novo Nordisk As | Derivados del polipeptido insulinotropico dependiente de la glucosa (gip) y usos de estos. |
| WO2020115048A1 (en) * | 2018-12-03 | 2020-06-11 | Antag Therapeutics Aps | Modified gip peptide analogues |
| MX2022006737A (es) * | 2019-12-03 | 2022-06-14 | Antag Therapeutics Aps | Analogos peptidicos del peptido insulinotropico dependiente de glucosa (gip) optimizados. |
| WO2023139106A2 (en) | 2022-01-18 | 2023-07-27 | Novo Nordisk A/S | Long-acting gipr antagonists |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5869602A (en) | 1995-03-17 | 1999-02-09 | Novo Nordisk A/S | Peptide derivatives |
| US6458924B2 (en) | 1996-08-30 | 2002-10-01 | Novo Nordisk A/S | Derivatives of GLP-1 analogs |
| CA2264243C (en) | 1996-08-30 | 2004-10-05 | Novo Nordisk A/S | Glp-1 derivatives |
| US6268343B1 (en) | 1996-08-30 | 2001-07-31 | Novo Nordisk A/S | Derivatives of GLP-1 analogs |
| WO1998024464A1 (en) | 1996-12-03 | 1998-06-11 | Trustees Of Boston University | Specific antagonists for glucose-dependent insulinotropic polypeptide (gip) |
| CZ297361B6 (cs) | 1998-01-30 | 2006-11-15 | Novo Nordisk A/S | Injekcní stríkacka |
| WO1999043708A1 (en) | 1998-02-27 | 1999-09-02 | Novo Nordisk A/S | Glp-1 derivatives of glp-1 and exendin with protracted profile of action |
| DE69918070T2 (de) | 1998-03-13 | 2005-08-25 | Novo Nordisk A/S | Stabilisierte, wässrige Glukagonlösungen, enthaltend Detergenzien |
| WO2000020592A1 (en) | 1998-10-07 | 2000-04-13 | Medical College Of Georgia Research Institute, Inc. | Glucose-dependent insulinotropic peptide for use as an osteotropic hormone |
| CN1495198A (zh) | 1998-12-07 | 2004-05-12 | �о���Ӧ�ÿ�ѧЭ��ɷ�����˾ | 胰高血糖素样肽-1的类似物 |
| US6921748B1 (en) | 1999-03-29 | 2005-07-26 | Uutech Limited | Analogs of gastric inhibitory polypeptide and their use for treatment of diabetes |
| GB0404124D0 (en) * | 2004-02-25 | 2004-03-31 | Univ Ulster | Antagonists of GIP |
| US20050272652A1 (en) | 1999-03-29 | 2005-12-08 | Gault Victor A | Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity |
| PT1355942E (pt) | 2000-12-07 | 2008-11-21 | Lilly Co Eli | Proteínas de fusão de glp-1 |
| US20030232761A1 (en) | 2002-03-28 | 2003-12-18 | Hinke Simon A. | Novel analogues of glucose-dependent insulinotropic polypeptide |
| US20050059605A1 (en) | 2003-01-31 | 2005-03-17 | Krishna Peri | Chemically modified metabolites of regulatory peptides and methods of producing and using same |
| EA011653B1 (ru) | 2005-02-11 | 2009-04-28 | Амилин Фармасьютикалз, Инк. | Аналоги и гибридные полипептиды gip с избираемыми свойствами |
| US8263545B2 (en) | 2005-02-11 | 2012-09-11 | Amylin Pharmaceuticals, Inc. | GIP analog and hybrid polypeptides with selectable properties |
| TWI362392B (en) | 2005-03-18 | 2012-04-21 | Novo Nordisk As | Acylated glp-1 compounds |
| US20090186817A1 (en) | 2006-03-21 | 2009-07-23 | Amylin Pharmaceuticals, Inc. | Peptide-peptidase inhibitor conjugates and methods of using same |
| AU2007284365A1 (en) | 2006-08-17 | 2008-02-21 | Amylin Pharmaceuticals, Inc. | DPP-IV resistant GIP hybrid polypeptides with selectable properties |
| PL2320923T3 (pl) | 2008-08-07 | 2015-06-30 | Ipsen Pharma Sas | Skrócone analogi peptydu insulinotropowego zależnego od glukozy |
| JP2011530507A (ja) | 2008-08-07 | 2011-12-22 | イプセン ファルマ ソシエテ パール アクシオン サンプリフィエ | グルコース依存性インスリン分泌刺激ポリペプチドアナログ |
| WO2010016936A1 (en) | 2008-08-07 | 2010-02-11 | Ipsen Pharma S.A.S. | Pharmaceutical compositions of analogues of glucose-dependent insulinotropic polypeptide |
| JP2011530508A (ja) | 2008-08-07 | 2011-12-22 | イプセン ファルマ ソシエテ パール アクシオン サンプリフィエ | グルコース依存性インスリン分泌刺激ポリペプチドのアナログ |
| WO2010016944A2 (en) | 2008-08-07 | 2010-02-11 | Ipsen Pharma S.A.S. | Analogues of glucose-dependent insulinotropic polypeptide (gip) modified at n-terminal |
| CN102834108A (zh) | 2010-01-27 | 2012-12-19 | 印第安纳大学研究及科技有限公司 | 用于治疗代谢紊乱和肥胖症的胰高血糖素拮抗剂-gip激动剂偶联物和组合物 |
| US9023986B2 (en) | 2010-10-25 | 2015-05-05 | Hoffmann-La Roche Inc. | Glucose-dependent insulinotropic peptide analogs |
| CN103402536A (zh) | 2010-12-22 | 2013-11-20 | 马克迪亚生物科技公司 | 用gip和glp-1受体活性的基于胰高血糖素的肽来治疗代谢异常和肥胖的方法 |
| JP5914641B2 (ja) * | 2011-06-10 | 2016-05-11 | ベイジン・ハンミ・ファーマシューティカル・カンパニー・リミテッドＢｅｉｊｉｎｇ Ｈａｎｍｉ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｃｏ．， Ｌｔｄ． | グルコース依存性インスリン分泌刺激ポリペプチドのアナログ、医薬組成物及びその使用 |
| WO2012168464A1 (en) * | 2011-06-10 | 2012-12-13 | Universität Bern | Imaging and treatment of neuroendocrine tumors with glucose - dependent insulinotropic polypeptide or analogues or antagonists thereof |
| JP2016521253A (ja) | 2013-03-15 | 2016-07-21 | インディアナ ユニヴァーシティ リサーチ アンド テクノロジー コーポレイション | 持続性作用を有するプロドラッグ |
| WO2016034186A1 (en) * | 2014-09-05 | 2016-03-10 | University Of Copenhagen | Gip peptide analogues |
| DK3212218T3 (da) | 2014-10-29 | 2021-08-30 | Zealand Pharma As | GIP-agonistforbindelser og fremgangsmåder |
| US20190000928A1 (en) | 2015-06-17 | 2019-01-03 | The California Institute For Biomedical Research | Modified therapeutic agents and compositions thereof |
| US10774127B2 (en) * | 2016-10-12 | 2020-09-15 | University Of Copenhagen | Peptide dual agonists of GIPR and GLP2R |
| CN110087686A (zh) | 2016-12-26 | 2019-08-02 | 花王株式会社 | 认知功能改善剂 |
| EP3560514A4 (en) | 2016-12-26 | 2020-12-23 | Kao Corporation | Hypothermic drugs |
| JP7165495B2 (ja) | 2016-12-26 | 2022-11-04 | 花王株式会社 | 運動調節機能向上剤 |
| KR102743887B1 (ko) | 2017-05-31 | 2024-12-19 | 유니버시티 오브 코펜하겐 | 장기-작용성 gip 펩타이드 유사체 |
-
2018
- 2018-05-31 KR KR1020197034279A patent/KR102743887B1/ko active Active
- 2018-05-31 ES ES18728872T patent/ES2972848T3/es active Active
- 2018-05-31 JP JP2019565921A patent/JP2020521784A/ja active Pending
- 2018-05-31 EP EP24150677.3A patent/EP4361173A3/en active Pending
- 2018-05-31 EP EP18728872.5A patent/EP3630806B1/en active Active
- 2018-05-31 WO PCT/EP2018/064355 patent/WO2018220123A1/en not_active Ceased
- 2018-05-31 US US16/617,698 patent/US11572399B2/en active Active
- 2018-05-31 PL PL18728872.5T patent/PL3630806T3/pl unknown
- 2018-05-31 CN CN201880036341.0A patent/CN110691788B/zh active Active
- 2018-05-31 BR BR112019025195A patent/BR112019025195A8/pt unknown
- 2018-05-31 AU AU2018276434A patent/AU2018276434B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA3064510A1 (en) | 2018-12-06 |
| KR20200014287A (ko) | 2020-02-10 |
| KR102743887B1 (ko) | 2024-12-19 |
| BR112019025195A8 (pt) | 2020-07-07 |
| BR112019025195A2 (pt) | 2020-06-23 |
| AU2018276434B2 (en) | 2021-12-16 |
| CN110691788B (zh) | 2024-05-31 |
| EP3630806B1 (en) | 2024-01-10 |
| US20200087373A1 (en) | 2020-03-19 |
| EP4361173A2 (en) | 2024-05-01 |
| EP4361173A3 (en) | 2024-07-03 |
| CN110691788A (zh) | 2020-01-14 |
| ES2972848T3 (es) | 2024-06-17 |
| EP3630806A1 (en) | 2020-04-08 |
| WO2018220123A1 (en) | 2018-12-06 |
| AU2018276434A1 (en) | 2020-01-02 |
| JP2020521784A (ja) | 2020-07-27 |
| US11572399B2 (en) | 2023-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11202105586YA (en) | Modified gip peptide analogues | |
| IL269581A (en) | GIP receptor activating peptide | |
| ZA201901253B (en) | Amylin analogues | |
| IL277483B1 (en) | New anti-GLP-1 analogs | |
| IL275298A (en) | Mitochondria-targeted peptides | |
| IL275129A (en) | New spirobicyclic analogs | |
| SG11201912812RA (en) | Scrubber | |
| PL3630806T3 (pl) | Analogi peptydów gip o długotrwałym działaniu | |
| GB201719557D0 (en) | Polypeptide | |
| IL253924A0 (en) | Amylin analogs | |
| ZA202000215B (en) | Long-acting formulations | |
| SG10202109234YA (en) | Novel peptide | |
| EP3645031A4 (en) | PEPTIDIC ANALOGUES | |
| SG11202005653RA (en) | Novel peptide | |
| IL273387A (en) | Thylanstatin analogs | |
| PL3189072T3 (pl) | Analogi peptydowe gip | |
| GB201506316D0 (en) | Novel peptide | |
| GB201406581D0 (en) | PAP Peptide analogues | |
| IL257803B (en) | Peptide analogs derived from vdac1 | |
| GB201401673D0 (en) | Esculentin-2CHa peptide and analogues thereof | |
| GB201719520D0 (en) | Neuroprotectvie peptide | |
| GB201708982D0 (en) | Tunicamycin analogues | |
| HK40060357A (en) | Modified gip peptide analogues | |
| GB201814440D0 (en) | Peptide | |
| GB201803074D0 (en) | Peptide |